BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 31314613)

  • 1. Metoclopramide for the treatment of diabetic gastroparesis.
    Shakhatreh M; Jehangir A; Malik Z; Parkman HP
    Expert Rev Gastroenterol Hepatol; 2019 Aug; 13(8):711-721. PubMed ID: 31314613
    [No Abstract]   [Full Text] [Related]  

  • 2. Metoclopramide nasal spray for management of symptoms of acute and recurrent diabetic gastroparesis in adults.
    Gajendran M; Sarosiek I; McCallum R
    Expert Rev Endocrinol Metab; 2021 Mar; 16(2):25-35. PubMed ID: 33739209
    [No Abstract]   [Full Text] [Related]  

  • 3. Gastroparesis, metoclopramide, and tardive dyskinesia: Risk revisited.
    Al-Saffar A; Lennernäs H; Hellström PM
    Neurogastroenterol Motil; 2019 Nov; 31(11):e13617. PubMed ID: 31050085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic metoclopramide therapy for diabetic gastroparesis.
    Lata PF; Pigarelli DL
    Ann Pharmacother; 2003 Jan; 37(1):122-6. PubMed ID: 12503946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review of a new gastrointestinal drug--metoclopramide.
    Ponte CD; Nappi JM
    Am J Hosp Pharm; 1981 Jun; 38(6):829-33. PubMed ID: 7018232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Domperidone versus metoclopramide in the treatment of diabetic gastroparesis.
    Dumitrascu DL; Weinbeck M
    Am J Gastroenterol; 2000 Jan; 95(1):316-7. PubMed ID: 10638616
    [No Abstract]   [Full Text] [Related]  

  • 7. Current and emerging pharmacotherapy for the treatment of gastroparesis.
    Kalas MA; Sarosiek I; McCallum RW
    Expert Opin Pharmacother; 2024 Apr; 25(5):541-549. PubMed ID: 38629943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding diabetic gastroparesis: a case study.
    Tonzi MK; Fain JA
    Gastroenterol Nurs; 2002; 25(4):154-60; quiz 161-2. PubMed ID: 12195149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review article: The diagnosis and management of gastroparesis.
    Haans JJ; Masclee AA
    Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():37-46. PubMed ID: 18081647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of metoclopramide on gastric liquid emptying in patients with diabetic gastroparesis.
    Schade RR; Dugas MC; Lhotsky DM; Gavaler JS; Van Thiel DH
    Dig Dis Sci; 1985 Jan; 30(1):10-5. PubMed ID: 3965270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of metoclopramide, domperidone, and cisapride in the management of diabetic gastroparesis.
    Brown CK; Khanderia U
    Clin Pharm; 1990 May; 9(5):357-65. PubMed ID: 2190745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetic gastroparesis: An overview of pathogenesis, clinical presentation and novel therapies, with a focus on ghrelin receptor agonists.
    Petri M; Singh I; Baker C; Underkofler C; Rasouli N
    J Diabetes Complications; 2021 Feb; 35(2):107733. PubMed ID: 32948398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The metoclopramide black box warning for tardive dyskinesia: effect on clinical practice, adverse event reporting, and prescription drug lawsuits.
    Ehrenpreis ED; Deepak P; Sifuentes H; Devi R; Du H; Leikin JB
    Am J Gastroenterol; 2013 Jun; 108(6):866-72. PubMed ID: 23735907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological Approaches to Diabetic Gastroparesis: A systematic review of randomised clinical trials.
    Asha MZ; Khalil SFH
    Sultan Qaboos Univ Med J; 2019 Nov; 19(4):e291-e304. PubMed ID: 31897312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical response and side effects of metoclopramide: associations with clinical, demographic, and pharmacogenetic parameters.
    Parkman HP; Mishra A; Jacobs M; Pathikonda M; Sachdeva P; Gaughan J; Krynetskiy E
    J Clin Gastroenterol; 2012 Jul; 46(6):494-503. PubMed ID: 22688145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathophysiology and pharmacotherapy of gastroparesis: current and future perspectives.
    Stevens JE; Jones KL; Rayner CK; Horowitz M
    Expert Opin Pharmacother; 2013 Jun; 14(9):1171-86. PubMed ID: 23663133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of metoclopramide in diabetic gastroparesis.
    Ricci DA; Saltzman MB; Meyer C; Callachan C; McCallum RW
    J Clin Gastroenterol; 1985 Feb; 7(1):25-32. PubMed ID: 3884697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of metoclopramide and erythromycin in the treatment of diabetic gastroparesis.
    Erbas T; Varoglu E; Erbas B; Tastekin G; Akalin S
    Diabetes Care; 1993 Nov; 16(11):1511-4. PubMed ID: 8299441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metoclopramide-stimulated gastric emptying scintigraphy: does it predict symptom response to prokinetic therapy in chronic gastroparesis?
    Lyday WD; DiBaise JK
    Am J Gastroenterol; 2002 Sep; 97(9):2474-6. PubMed ID: 12358283
    [No Abstract]   [Full Text] [Related]  

  • 20. Metoclopramide to treat gastroparesis due to diabetes mellitus: a double-blind, controlled trial.
    Snape WJ; Battle WM; Schwartz SS; Braunstein SN; Goldstein HA; Alavi A
    Ann Intern Med; 1982 Apr; 96(4):444-6. PubMed ID: 7065559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.